Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy for Caregiver Insomnia
Study Summary
This trial will focus on improving sleep for caregivers of children with ASD and insomnia by comparing a home-based tailored CBT for Insomnia (CBT-I) intervention to a web-based Way to Health CBT-I intervention.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with insomnia related to behavior or autism.I will keep my medication doses consistent and unchanged.You have access to a phone and the internet.I am a child aged 3-17 or their parent.A parent or guardian must give permission for a child to participate.I have been diagnosed with insomnia.My caregiver is 18 years old or older.
- Group 1: web-based
- Group 2: Home-based
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are geriatric participants able to enter this experiment?
"According to the official requirements, this trial is available for those between 3 and 100 years old. There are 247 trials open specifically for minors and 258 studies targeting seniors."
What is the aggregate figure of individuals who have signed up for participation in this experiment?
"Affirmative. Information from clinicaltrials.gov suggests that this medical investigation is actively enrolling patients, with the initial post published on September 26th 2022 and last updated on September 21st 2022. 80 participants are needed at a single centre for completion of the trial."
What is the primary purpose of this clinical trial?
"The primary assessment of this clinical trial, over a 8 week period, will be the feasibility of pilot study. Secondary measurements include Change in Maternal Self-efficacy (via the 10 item Maternal-Self efficacy Scale with a minimum score of 10 and maximum 40), Change in Child Daytime behaviours (using T scores from 0 to 100 on the Child Behavior Checklist) and Change in wake after sleep onset as monitored by an actigraphy watch for caregivers (measured using average minutes per week)."
Are there any opportunities to participate in this experimental program?
"The clinical trial is currently seeking participants, as per the details available on clinicaltrials.gov; it was initially posted on September 26th 2022 and last updated on September 21st 2022."
What type of individuals are suitable candidates for this clinical experiment?
"This study seeks 80 minors between the ages of 3 and 100 as well as their caregivers. To qualify, patients must also meet a set of criteria: Caregivers must be 18 years or older; Diagnosis of Insomnia is necessary; Both parental/guardian permission (informed consent) for child participation and telephone/web access are mandatory; Maintenance of stable medication doses with no change in health status within the past three months is essential; For children age 3 to 17 years there needs to be diagnosis confirmation with either Autism Diagnostic Observation Schedule or DSM-IV criteria.; Stable medical and behavioural conditions are needed."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger